PATENT CLAIM ANALYSIS

Application Number: 15773134
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "422000"]

Abstract:
The present invention relates to novel pharmaceutical formulations. More specifically, the present invention relates to novel pharmaceutical formulations that are suitable for intraocular administration. The present invention also relates to the use of these formulations for the treatment of collagenic eye disorder such as, for example, the treatment of keratoconus.

Claim (Index 9):
A pharmaceutical composition according to  claim 1 , wherein the composition further comprises a buffer to maintain the pH of the composition within the range of pH 6 to 9.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.80645
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15566034', '14240328', '13766142', '12867566', '12023977']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7276666378096525
- 35 USC 102 Novelty (BERT): 0.516748067061447
- Combined Prediction Score: 0.7065747807348319
- Mean Citation Score: 211.996236
- Max Citation Score: 241.5023
- Similarity Product: 151.38960547783375

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test